RHHBY - Roche Holding AG
| Previous Close | 32.72 |
| Open | 32.77 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 32.48 - 32.86 |
| 52 Week Range | 26.30 - 34.98 |
| Volume | 1,265,198 |
| Avg. Volume | 1,095,819 |
| Market Cap | 224.681B |
| Beta (3Y Monthly) | 0.50 |
| PE Ratio (TTM) | 21.29 |
| EPS (TTM) | 1.54 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.07 (3.12%) |
| Ex-Dividend Date | 2019-03-07 |
| 1y Target Est | 35.55 |
- Yahoo Finance Video•2 days ago
Walmart teams with Kidbox for clothing subscription service
Walmart is stepping into the subscription box space. The retailer is teaming up with Kidbox to deliver curated clothing boxes to its customers, including such brands as Miniville, Material Girl, Jessica Simpson and Chickpea. Yahoo Finance's Dan Roberts, Kristin Myers, and Julia La Roche sat down with Kidbox's CEO Miki Berardelli to discuss the partnership.
- Yahoo Finance Video•3 days ago
Walmart partners with KIDBOX for style subscription delivery for kids
Walmart is partnering with Kidbox to launch a subscription delivery box for kids. Yahoo Finance's Julia La Roche and Alexis Christoforous discuss.
- Yahoo Finance Video•5 days ago
Goldman Sachs posts mixed Q1 results, sees drop in trading revenue
Yahoo Finance's Akiko Fujita and Julia La Roche discuss Goldman Sachs Q1 earnings.
Yahoo Finance Video•8 days agoJPMorgan earnings beat expectations, stock jumps
JPMorgan Chase posted adjusted earnings per share of $2.65, versus analysts’ forecasts of $2.35 for the first quarter Friday. Yahoo Finance’s Julia La Roche and Alexis Christoforous break down the details.
Yahoo Finance Video•9 days agoJeff Bezos makes the case for why Amazon is tiny in retail
Jeff Bezos is out with his annual letter to Amazon shareholders, which started with "Third-party sellers are kicking out first party butt.' Yahoo Finance's Seana Smith and Julia La Roche discuss.
- Yahoo Finance Video•9 days ago
IRS changes to W-4 could make more work for taxpayers
The IRS plans to release a new W-4 form that would make the tax withholdings in your paychecks more accurate, better reflecting the new tax law, but the changes could leave you with more paperwork. The goal is to get taxpayers to net zero by the time April rolls around, meaning they wouldn't owe or be owed any money. The head of government affairs at ADP told USA Today that "The accuracy will be 100 percent, but the ease-of-use will be zero.” Yahoo Finance’s Melody Hahm, Myles Udland, and Julia La Roche discuss their takes on the form changes and what they do to make tax time easier.
- Yahoo Finance Video•9 days ago
Netflix in talks to buy Egyptian Theatre in Hollywood
Netflix is in early talks to buy Hollywood's Egyptian Theatre, which would be the streaming giant's first movie theatre acquisition. Yahoo Finance's Melody Hahm, Julia La Roche, and Myles Udland discuss what this acquisition means for Netflix and viewers.
- Yahoo Finance Video•10 days ago
Walmart adds thousands of new robots to stores
Walmart is doubling down on robot janitors, adding thousands of robots to their stores. Yahoo Finance's Zack Guzman, Julia La Roche, and Heidi Chung are joined by Danielle DiMartino Booth, Quill Intelligence CEO and Director of Intelligence, to discuss.
- Yahoo Finance Video•10 days ago
Walmart plans to add thousands of robot helpers to U.S. stores
Walmart is rolling out technology that will automate a range of low-level tasks at U.S. stores, allowing associates to have more time to do more specialized work.
- Zacks•yesterday
Roche's (RHHBY) Q1 Sales Strong on Solid Demand for New Drugs
Roche's (RHHBY) performance in the first quarter of 2019 is driven by solid strength of new drugs, which more than offset competition from biosimilars.
- Investor's Business Daily•2 days ago
Why A Highly Rated Biotech With A 54% Gain This Year Is Being Gutted
Ionis Pharmaceuticals was slammed Wednesday on competitive gene-therapy data from Novartis' AveXis unit and amid apparently disappointing comments from Roche in Huntington's disease.
- Motley Fool•2 days ago
Here's Why Ionis Pharmaceuticals Slumped Today
Information from competitors and a collaborator sent the high-flying biotech lower.
- Benzinga•3 days ago
The Daily Biotech Pulse: Zolgensma Data, Roche Q1 Results, Brainsway IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 16) Eidos Therapeutics Inc (NASDAQ: EIDX )(reported fourth ...
- Reuters•3 days ago
Swiss drugmaker Roche ups outlook as sales growth offsets price hit
By John Miller ZURICH (Reuters) - Swiss drugmaker Roche lifted its 2019 outlook on Wednesday, as sales growth in China and the United States outpaced price declines it has suffered amid President Donald ...
- Reuters•3 days ago
Roche sees no Brexit interruption for patients
Roche holding ag ceo says sales growth for hemlibra primarily driven by non-inhibitors patients Roche holding ag ceo says spark therapeutics acquisition planned to be completed in first half Roche holding ...
- Financial Times•3 days ago
Roche raises 2019 outlook on strong first quarter
Roche, the Swiss drugmaker, has raised its full-year sales outlook on strong sales growth for the first three months of 2019. The company said it now expects mid-single digits sales growth for 2019 from low to mid-single digit range as forecast at the end of January. “We have started the year with strong sales growth, driven by the newly launched products in our Pharmaceuticals Division,” said Roche chief executive Severin Schwan.
- GlobeNewswire•3 days ago
Roche reports a strong start in 2019 and raises the outlook for the full-year
Basel, 17 April 2019 Group sales increase 8% 1 at constant exchange rates and 9% in Swiss francs Pharmaceuticals Division sales up 10%, driven mainly by Ocrevus, Perjeta, Hemlibra and Tecentriq Diagnostics ...
- Zacks•3 days ago
Novartis' (NVS) BLA for Ophthalmology Drug Accepted by FDA
The FDA accepts Novartis' (NVS) BLA seeking approval for brolucizumab for the treatment of wet AMD.
- Zacks•4 days ago
Bristol-Myers' Shareholders Vote for Celgene Acquisition
Bristol-Myers' (BMY) gets a green signal from a majority of its shareholders for the merger with Celgene Corporation.
- Zacks•7 days ago
Ophthotech Gets Rights to Gene Therapy for BEST Disease
Ophthotech (OPHT) obtains development/commercialization rights to AAV gene-therapy program for BEST1-related retinal diseases from Penn and UFRF.
- Zacks•8 days ago
Biotechnology Market on a Tear: 5 ETFs in Spotlight
Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.
- Benzinga•9 days ago
Cannabis Securities Trading on The OTC Markets Saw Dramatic Volume Increases In March
Even in what has been a notoriously high-volume sector, March was a particularly strong month for cannabis securities that trade on OTC Markets. Six of the top 10 most active securities in March on the ...
- Zacks•9 days ago
J&J (JNJ) to Kick-start Pharma Q1 Earnings: What's in Store?
J&J's (JNJ) sales growth in first-quarter 2019 is expected to be hurt by generic/biosimilar headwinds in the Pharma unit.
- Motley Fool•11 days ago
Here's Why ImmunoGen Tumbled 43% in March
A failed forward trial forced the biotech to take big steps back.
